Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells

David Erlinge, Junping You, Claes R Wahlestedt, Lars Edvinsson

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Adenosine triphosphate (ATP), a co-transmitter in sympathetic nerves and released from platelets, has recently been shown to stimulate growth of vascular smooth muscle cells. It might therefore contribute to the development of vascular hypertrophy seen in hypertension and atherosclerosis. We aimed at characterising the receptor mediating this mitogenic effect in rat aorta smooth muscle cells. The potency of agonists indicates a P2 purinoceptor since ATP {succeeds above single-line equals sign} ADP ≫AMP, adenosine. The P2X-receptor subtype, which is responsible for ATP induced vasoconstriction in rat aorta, does not mediate the mitogenic effect since α,β-methyleneATP had no effect and β,γ-methyleneATP had lower potency than ATP. The P2Y-receptor subtype was excluded since the selective agonist 2-methylthioATP had weak effect with lower potency than ATP. When we studied the involvement of other nucleotides similar effects were seen of the purines ATP, GTP and ITP; also the pyrimidine UTP had powerful mitogenic effects (Emax = 52% of ATP) with similar potency. Nucleotides with fewer phosphate groups showed a stepwise fall in mitogenic effect. This indicates involvement of a nucleotide-receptor (P2U). Ap4A were of equal potency and effect as ATP. There was strong correlation between the mitogenic effects of the nucleotides and analogues with both 45Ca2+-influx and inositol phosphate (IP) production, indicating that they may participate in mediating the mitogenic response. This is the first study describing the potencies for the mitogenic effects of the selective ATP-analogues and other nucleotides in vascular smooth muscle cells. The receptor characterisation indicates a nucleotide-receptor similar to the receptor which stimulates 45Ca2+-influx and inositol phosphate-formation in rat aorta smooth muscle cells. Substances related to ATP such as GTP, ITP, UTP and Ap4A which also can be released extracellularly in vivo stimulate mitogenesis of rat aorta smooth muscle cells through the same receptor.

Original languageEnglish
Pages (from-to)135-149
Number of pages15
JournalEuropean Journal of Pharmacology: Molecular Pharmacology
Volume289
Issue number1
DOIs
StatePublished - Mar 15 1995
Externally publishedYes

Fingerprint

Purinergic P1 Receptors
Vascular Smooth Muscle
Smooth Muscle Myocytes
Adenosine Triphosphate
Nucleotides
Aorta
Inosine Triphosphate
Uridine Triphosphate
Inositol Phosphates
Guanosine Triphosphate
Purinergic P2Y2 Receptors
Purinergic P2 Receptors
Purines
Adenosine Monophosphate
Vasoconstriction
Adenosine
Adenosine Diphosphate
Hypertrophy
Blood Vessels
Atherosclerosis

Keywords

  • ATP
  • ATP receptor
  • Mitosis
  • Smooth muscle cell

ASJC Scopus subject areas

  • Pharmacology

Cite this

Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells. / Erlinge, David; You, Junping; Wahlestedt, Claes R; Edvinsson, Lars.

In: European Journal of Pharmacology: Molecular Pharmacology, Vol. 289, No. 1, 15.03.1995, p. 135-149.

Research output: Contribution to journalArticle

@article{bada728269e64668ad156d0638d3bce5,
title = "Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells",
abstract = "Adenosine triphosphate (ATP), a co-transmitter in sympathetic nerves and released from platelets, has recently been shown to stimulate growth of vascular smooth muscle cells. It might therefore contribute to the development of vascular hypertrophy seen in hypertension and atherosclerosis. We aimed at characterising the receptor mediating this mitogenic effect in rat aorta smooth muscle cells. The potency of agonists indicates a P2 purinoceptor since ATP {succeeds above single-line equals sign} ADP ≫AMP, adenosine. The P2X-receptor subtype, which is responsible for ATP induced vasoconstriction in rat aorta, does not mediate the mitogenic effect since α,β-methyleneATP had no effect and β,γ-methyleneATP had lower potency than ATP. The P2Y-receptor subtype was excluded since the selective agonist 2-methylthioATP had weak effect with lower potency than ATP. When we studied the involvement of other nucleotides similar effects were seen of the purines ATP, GTP and ITP; also the pyrimidine UTP had powerful mitogenic effects (Emax = 52{\%} of ATP) with similar potency. Nucleotides with fewer phosphate groups showed a stepwise fall in mitogenic effect. This indicates involvement of a nucleotide-receptor (P2U). Ap4A were of equal potency and effect as ATP. There was strong correlation between the mitogenic effects of the nucleotides and analogues with both 45Ca2+-influx and inositol phosphate (IP) production, indicating that they may participate in mediating the mitogenic response. This is the first study describing the potencies for the mitogenic effects of the selective ATP-analogues and other nucleotides in vascular smooth muscle cells. The receptor characterisation indicates a nucleotide-receptor similar to the receptor which stimulates 45Ca2+-influx and inositol phosphate-formation in rat aorta smooth muscle cells. Substances related to ATP such as GTP, ITP, UTP and Ap4A which also can be released extracellularly in vivo stimulate mitogenesis of rat aorta smooth muscle cells through the same receptor.",
keywords = "ATP, ATP receptor, Mitosis, Smooth muscle cell",
author = "David Erlinge and Junping You and Wahlestedt, {Claes R} and Lars Edvinsson",
year = "1995",
month = "3",
day = "15",
doi = "10.1016/0922-4106(95)90178-7",
language = "English",
volume = "289",
pages = "135--149",
journal = "European Journal of Pharmacology - Molecular Pharmacology Section",
issn = "0922-4106",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells

AU - Erlinge, David

AU - You, Junping

AU - Wahlestedt, Claes R

AU - Edvinsson, Lars

PY - 1995/3/15

Y1 - 1995/3/15

N2 - Adenosine triphosphate (ATP), a co-transmitter in sympathetic nerves and released from platelets, has recently been shown to stimulate growth of vascular smooth muscle cells. It might therefore contribute to the development of vascular hypertrophy seen in hypertension and atherosclerosis. We aimed at characterising the receptor mediating this mitogenic effect in rat aorta smooth muscle cells. The potency of agonists indicates a P2 purinoceptor since ATP {succeeds above single-line equals sign} ADP ≫AMP, adenosine. The P2X-receptor subtype, which is responsible for ATP induced vasoconstriction in rat aorta, does not mediate the mitogenic effect since α,β-methyleneATP had no effect and β,γ-methyleneATP had lower potency than ATP. The P2Y-receptor subtype was excluded since the selective agonist 2-methylthioATP had weak effect with lower potency than ATP. When we studied the involvement of other nucleotides similar effects were seen of the purines ATP, GTP and ITP; also the pyrimidine UTP had powerful mitogenic effects (Emax = 52% of ATP) with similar potency. Nucleotides with fewer phosphate groups showed a stepwise fall in mitogenic effect. This indicates involvement of a nucleotide-receptor (P2U). Ap4A were of equal potency and effect as ATP. There was strong correlation between the mitogenic effects of the nucleotides and analogues with both 45Ca2+-influx and inositol phosphate (IP) production, indicating that they may participate in mediating the mitogenic response. This is the first study describing the potencies for the mitogenic effects of the selective ATP-analogues and other nucleotides in vascular smooth muscle cells. The receptor characterisation indicates a nucleotide-receptor similar to the receptor which stimulates 45Ca2+-influx and inositol phosphate-formation in rat aorta smooth muscle cells. Substances related to ATP such as GTP, ITP, UTP and Ap4A which also can be released extracellularly in vivo stimulate mitogenesis of rat aorta smooth muscle cells through the same receptor.

AB - Adenosine triphosphate (ATP), a co-transmitter in sympathetic nerves and released from platelets, has recently been shown to stimulate growth of vascular smooth muscle cells. It might therefore contribute to the development of vascular hypertrophy seen in hypertension and atherosclerosis. We aimed at characterising the receptor mediating this mitogenic effect in rat aorta smooth muscle cells. The potency of agonists indicates a P2 purinoceptor since ATP {succeeds above single-line equals sign} ADP ≫AMP, adenosine. The P2X-receptor subtype, which is responsible for ATP induced vasoconstriction in rat aorta, does not mediate the mitogenic effect since α,β-methyleneATP had no effect and β,γ-methyleneATP had lower potency than ATP. The P2Y-receptor subtype was excluded since the selective agonist 2-methylthioATP had weak effect with lower potency than ATP. When we studied the involvement of other nucleotides similar effects were seen of the purines ATP, GTP and ITP; also the pyrimidine UTP had powerful mitogenic effects (Emax = 52% of ATP) with similar potency. Nucleotides with fewer phosphate groups showed a stepwise fall in mitogenic effect. This indicates involvement of a nucleotide-receptor (P2U). Ap4A were of equal potency and effect as ATP. There was strong correlation between the mitogenic effects of the nucleotides and analogues with both 45Ca2+-influx and inositol phosphate (IP) production, indicating that they may participate in mediating the mitogenic response. This is the first study describing the potencies for the mitogenic effects of the selective ATP-analogues and other nucleotides in vascular smooth muscle cells. The receptor characterisation indicates a nucleotide-receptor similar to the receptor which stimulates 45Ca2+-influx and inositol phosphate-formation in rat aorta smooth muscle cells. Substances related to ATP such as GTP, ITP, UTP and Ap4A which also can be released extracellularly in vivo stimulate mitogenesis of rat aorta smooth muscle cells through the same receptor.

KW - ATP

KW - ATP receptor

KW - Mitosis

KW - Smooth muscle cell

UR - http://www.scopus.com/inward/record.url?scp=0028985704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028985704&partnerID=8YFLogxK

U2 - 10.1016/0922-4106(95)90178-7

DO - 10.1016/0922-4106(95)90178-7

M3 - Article

VL - 289

SP - 135

EP - 149

JO - European Journal of Pharmacology - Molecular Pharmacology Section

JF - European Journal of Pharmacology - Molecular Pharmacology Section

SN - 0922-4106

IS - 1

ER -